Nutritional psychiatry in the treatment of psychotic disorders: Current hypotheses and research challenges
- PMID: 34589852
- PMCID: PMC8474162
- DOI: 10.1016/j.bbih.2020.100070
Nutritional psychiatry in the treatment of psychotic disorders: Current hypotheses and research challenges
Abstract
Current treatment for schizophrenia-spectrum disorders focusses primarily on psychotropic medication to treat symptoms, though their efficacy varies between patients and psychotropic medication is often accompanied by severe side effects. Nutritional interventions to prevent and treat mental illness have received considerable attention over recent years. However, evidence for nutritional interventions in schizophrenia-spectrum disorders remains limited in quantity and quality. Pathways currently in focus include: i) nutritional deficits and impairments in glucose metabolism, ii) inflammation and immune dysregulation (also known from the mild encephalitis hypothesis), and iii) altered gut microbiota. All of which appear to be interconnected. Key limiting factors for advancing research in this field are research challenges associated with assessing and interpreting inflammatory profiles, microbiota and subjective nutritional assessments, which is further complicated by illness characteristics. This review describes the state of evidence for key hypotheses, including underlying mechanisms, implicated in schizophrenia-spectrum disorders, the challenges in nutritional psychiatry research and the current state of nutrition interventions in mental healthcare.
Keywords: Diet; Gut-brain axis; Mental health; Nutritional psychiatry; Psychosis; Research challenges.
© 2020 The Authors.
Conflict of interest statement
None.
Figures



Similar articles
-
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383. Med J Aust. 2019. PMID: 31679171
-
Nutritional psychiatry: the present state of the evidence.Proc Nutr Soc. 2017 Nov;76(4):427-436. doi: 10.1017/S0029665117002026. Epub 2017 Sep 25. Proc Nutr Soc. 2017. PMID: 28942748 Review.
-
Insight across mental disorders: A multifaceted metacognitive phenomenon.Psychiatriki. 2019 Jan-Mar;30(1):13-16. doi: 10.22365/jpsych.2019.301.13. Psychiatriki. 2019. PMID: 31115349 English, Greek, Modern.
-
[Stress and psychotic transition: A literature review].Encephale. 2016 Aug;42(4):367-73. doi: 10.1016/j.encep.2015.10.001. Epub 2016 May 6. Encephale. 2016. PMID: 27161263 Review. French.
-
Social challenges of contemporary psychiatry.Psychiatriki. 2017 Jul-Sep;28(3):119-202. doi: 10.22365/jpsych.2017.283.199. Psychiatriki. 2017. PMID: 29072182 English, Greek, Modern.
Cited by
-
The Development of a Nutrition Screening Tool for Mental Health Settings Prone to Obesity and Cardiometabolic Complications: Study Protocol for the NutriMental Screener.Int J Environ Res Public Health. 2021 Oct 27;18(21):11269. doi: 10.3390/ijerph182111269. Int J Environ Res Public Health. 2021. PMID: 34769787 Free PMC article.
-
Human gut microbiome, diet, and mental disorders.Int Microbiol. 2025 Jan;28(1):1-15. doi: 10.1007/s10123-024-00518-6. Epub 2024 Apr 1. Int Microbiol. 2025. PMID: 38561477 Free PMC article. Review.
-
The relationship between psychology practice and complementary medicine in Australia: Psychologists' demographics and practice characteristics regarding type of engagement across a range of complementary medicine modalities.PLoS One. 2023 May 4;18(5):e0285050. doi: 10.1371/journal.pone.0285050. eCollection 2023. PLoS One. 2023. PMID: 37141280 Free PMC article.
-
Design and pilot evaluation of an evidence-based worksheet and clinician guide to facilitate nutrition counselling for patients with severe mental illness.BMC Psychiatry. 2021 Nov 10;21(1):556. doi: 10.1186/s12888-021-03575-7. BMC Psychiatry. 2021. PMID: 34758760 Free PMC article.
-
Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis.Front Psychiatry. 2023 Jun 27;14:1189768. doi: 10.3389/fpsyt.2023.1189768. eCollection 2023. Front Psychiatry. 2023. PMID: 37441144 Free PMC article.
References
-
- Akhondzadeh S., Tabatabaee M., Amini H., Abhari S.A.A., Abbasi S.H., Behnam B. Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr. Res. 2007;90(1–3):179–185. - PubMed
-
- Allott K., McGorry P.D., Yuen H.P., Firth J., Proffitt T.-M., Berger G. The Vitamins in Psychosis study: a randomized, double-blind, placebo-controlled trial of the effects of vitamins B12, B6, and folic acid on symptoms and neurocognition in first-episode psychosis. Biol. Psychiatr. 2019;86(1):35–44. - PubMed
-
- Babulas V., Factor-Litvak P., Goetz R., Schaefer C.A., Brown A.S. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am. J. Psychiatr. 2006;163(5):927–929. - PubMed
LinkOut - more resources
Full Text Sources